Items where Author is "Turner, Joseph D"
Up a level |
Group by: Item Type | No Grouping
Number of items: 4.
Hegde, Shrilakshmi, Marriott, Amy E, Pionnier, Nicolas ORCID: https://orcid.org/0000-0002-2379-4945, Steven, Andrew, Bulman, Christina, Gunderson, Emma, Vogel, Ian, Koschel, Marianne, Ehrens, Alexandra, Lustigman, Sara, Voronin, Denis, Tricoche, Nancy, Hoerauf, Achim, Hübner, Marc P, Sakanari, Judy, Aljayyoussi, Ghaith, Gusovsky, Fabian, Dagley, Jessica, Hong, David W, O'Neill, Paul, Ward, Steven A, Taylor, Mark J and Turner, Joseph D
(2024)
Combinations of the azaquinazoline anti-Wolbachia agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasis.
Frontiers in Microbiology, 15.
ISSN 1664-302X
Marriott, Amy E, Furlong Silva, Julio, Pionnier, Nicolas ORCID: https://orcid.org/0000-0002-2379-4945, Sjoberg, Hanna, Archer, John, Steven, Andrew, Kempf, Dale, Taylor, Mark J and Turner, Joseph D
(2022)
A mouse infection model and long-term lymphatic endothelium co-culture system to evaluate drugs against adult Brugia malayi.
PLoS Neglected Tropical Diseases, 16 (6).
e0010474.
ISSN 1935-2727
Akumtoh, Desmond N, Njouendou, Abdel J, Metuge, Haelly M, Sjoberg, Hanna T, Pionnier, Nicolas P, Chunda, Valerine C, Gandjui, Narcisse Victor T, Ndzeshang, Lontum B, Fombad, Fanny F, Abong, Raphael A, Enyong, Peter A, Fru-Cho, Jerome, Esum, Mathias E, Ritter, Manuel, Taylor, Mark J, Turner, Joseph D and Wanji, Samuel
(2021)
Onchocerca ochengi male worms implanted in SCID mice and gerbil: relationship between microfilaridermia status of cows, nodular worm viability and fertility and worm survival in the rodents.
Experimental Parasitology, 229.
p. 108143.
ISSN 0014-4894
Furlong-Silva, Julio, Cross, Stephen D, Marriott, Amy E, Pionnier, Nicolas ORCID: https://orcid.org/0000-0002-2379-4945, Archer, John, Steven, Andrew, Merker, Stefan Schulte, Mack, Matthias, Hong, Young-Kwon, Taylor, Mark J and Turner, Joseph D
(2021)
Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis.
Journal of Clinical Investigation, 131 (5).
ISSN 0021-9738